Truist raises Guardian Pharmacy target to $47
Truist Securities analyst David Macdonald has maintained a Buy rating on Guardian Pharmacy Service, increasing the price target to $47 from $43, signaling a positive outlook for the stock.
*this image is generated using AI for illustrative purposes only.
Truist Securities analyst David Macdonald has maintained a Buy rating on Guardian Pharmacy Service, raising the price target to $47 from the previous $43. The revised target indicates a positive outlook on the company's stock performance.
Analyst Recommendation
The decision to uphold the Buy rating comes alongside a higher price objective, suggesting potential upside for Guardian Pharmacy Service shares. The new target of $47 represents an increase over the prior estimate of $43.
| Metric | Value |
|---|---|
| Rating | Buy |
| Previous Price Target | $43 |
| New Price Target | $47 |
What specific factors drove Truist Securities to raise the price target for Guardian Pharmacy Service?
How might Guardian Pharmacy Service's recent performance influence other analysts' ratings?
What are the potential risks that could prevent Guardian Pharmacy Service from reaching the $47 price target?
17
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
